Skip to main content

Advertisement

SpringerLink
Log in

Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3

References

  1. Heisterkamp N, Groffen J . BCR/ABL gene structure and BCR function. In: Carella AM, Daley GQ, Eaves CM, Goldman JM, Hehlman R (eds). Chronic Myeloid Leukemia: Biology and Treatment. Martin Dunitz Ltd: UK, 2001, pp 3–17.

    Google Scholar 

  2. Deininger M, Buchdunger E, Druker BJ . The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 2005; 105: 2640–2653.

    Article  CAS  Google Scholar 

  3. Hofmann WK, Komor M, Hoelzer D, Ottmann OG . Mechanisms of resistance to STI571 (Imatinib) in Philadelphia-chromosome positive acute lymphoblastic leukemia. Leuk Lymphoma 2004; 45: 655–660.

    Article  CAS  Google Scholar 

  4. Ren R . Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 2005; 5: 172–183.

    Article  CAS  Google Scholar 

  5. Mishra S, Reichert A, Cunnick J, Senadheera D, Hemmeryckx B, Heisterkamp N et al. Protein kinase CKIIalpha interacts with the Bcr moiety of Bcr/Abl and mediates proliferation of Bcr/Abl-expressing cells. Oncogene 2003; 22: 8255–8262.

    Article  CAS  Google Scholar 

  6. Tawfic S, Yu S, Wang H, Faust R, Davis A, Ahmed K . Protein kinase CK2 signal in neoplasia. Histol. Histopathol 2001; 16: 573–582.

    CAS  PubMed  Google Scholar 

  7. Piazza F, Ruzzene M, Gurrieri C, Montini B, Bonanni L, Chioetto G et al. Multiple myeloma cell survival relies on high activity of protein kinase CK2. Blood 2006; 108: 1698–1707.

    Article  CAS  Google Scholar 

  8. Pagano MA, Meggio F, Ruzzene M, Andrzejewska M, Kazimierczuk Z, Pinna LA . 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2. Biochem Biophys Res Commun 2004; 321: 1040–1044.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Jess Cunnick for advice and help with the leukemia–MEF co-culture system. This work was supported by PHS Grant CA90321 (NH), the Kenneth T and Eileen L Norris Foundation (SM, VP, BZ, PK, JG) and the TJ Martell Foundation (JG and NH) and by AIRC and Integrated EU Project ‘Orokinase Research’ LSHB-CT-2004-503467 (LAP).

Author information

Author notes

  1. S Mishra

    Present address: Department of Pediatrics, Division of Research Immunology and Bone Marrow Transplantation, Childrens Hospital Los Angeles, LA, USA

Authors and Affiliations

  1. Department of Pediatrics, Division of Hematology/Oncology, Childrens Hospital Los Angeles Saban Research Institute and the Keck School of Medicine, University of Southern California, LA, USA

    S Mishra, V Pertz, B Zhang, P Kaur, J Groffen & N Heisterkamp

  2. Department of Pathology, Childrens Hospital Los Angeles Saban Research Institute and the Keck School of Medicine, University of Southern California, LA, USA

    H Shimada

  3. Department of Experimental Pharmacology, Laboratory of Experimental Pharmacology, Polish Academy of Sciences Medical Research Center, Warsaw, Poland

    Z Kazimierczuk

  4. Department of Biological Chemistry, University of Padova and Venetian Institute for Molecular Medicine, Padova, Italy

    L A Pinna

Authors
  1. S Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V Pertz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H Shimada
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J Groffen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Z Kazimierczuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. L A Pinna
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. N Heisterkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mishra, S., Pertz, V., Zhang, B. et al. Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2. Leukemia 21, 178–180 (2007). https://doi.org/10.1038/sj.leu.2404460

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404460

  • Springer Nature Limited

This article is cited by

Search

Navigation